• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treating risk, risking treatment: experiences of iatrogenesis in the HIV/AIDS and opioid epidemics.应对风险,冒险治疗:艾滋病病毒/艾滋病和阿片类药物流行中的医源性经历。
Anthropol Med. 2021 Jun;28(2):239-254. doi: 10.1080/13648470.2021.1926916. Epub 2021 Jun 30.
2
Iatrogenic trainwrecks and moral injury.医源性灾难和道德伤害。
Anthropol Med. 2021 Jun;28(2):223-238. doi: 10.1080/13648470.2021.1929831. Epub 2021 May 31.
3
HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.艾滋病病毒(HIV)感染者预防用药(PrEP)的处方可能性因患者类型而异:一份简短报告。
AIDS Care. 2016 Sep;28(9):1154-8. doi: 10.1080/09540121.2016.1153595. Epub 2016 Feb 26.
4
Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies.男男性行为者(MSM)人群在使用暴露前预防(PrEP)进行 HIV 预防时遇到的障碍:系统评价和定性研究的荟萃元分析。
AIDS Care. 2021 Jun;33(6):697-705. doi: 10.1080/09540121.2020.1778628. Epub 2020 Jun 12.
5
Pre-exposure Prophylaxis Knowledge and Use Among Men Who Have Sex With Men in a Small Metropolitan Region of the Southeastern United States.美国东南部一个小都会地区男男性行为者的暴露前预防知识和使用情况。
J Assoc Nurses AIDS Care. 2020 Jan-Feb;31(1):80-91. doi: 10.1097/JNC.0000000000000115.
6
Reflections on the history of bareback sex through ethnography: the works of subjectivity and PrEP.通过民族志对无保护性行为历史的反思:主体性与暴露前预防的作用
Anthropol Med. 2019 Dec;26(3):345-359. doi: 10.1080/13648470.2017.1365430. Epub 2017 Nov 27.
7
Body/Selves and Beyond: Men's Narratives of Sexual Behavior on PrEP.身体/自我与超越:接受暴露前预防用药男性性行为的叙事研究
Med Anthropol. 2018 Jul;37(5):387-400. doi: 10.1080/01459740.2017.1416608. Epub 2018 Jan 19.
8
Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.南非开普敦男男性行为者样本中基于抗逆转录病毒疗法的HIV预防:暴露后预防的使用情况及暴露前预防知识
AIDS Behav. 2016 Dec;20(Suppl 3):357-364. doi: 10.1007/s10461-016-1536-1.
9
Pre-exposure prophylaxis makes it possible to better live one's sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about primary motivations for PrEP.暴露前预防措施使人们能够更好地享受性生活,并引导男男性行为者对自己的健康负责:关于 PrEP 主要动机的现象学定性研究。
AIDS Res Ther. 2021 Jan 7;18(1):2. doi: 10.1186/s12981-020-00327-7.
10
Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.韩国医务人员和男男性行为者对 HIV 暴露前预防的认识和接受程度。
J Korean Med Sci. 2018 Mar 19;33(12):e91. doi: 10.3346/jkms.2018.33.e91.

引用本文的文献

1
Comparing PrEP use among men who have sex with men with a recent incarceration history.比较有近期监禁史的男男性行为者中暴露前预防药物的使用情况。
AIDS Care. 2025 May;37(5):709-719. doi: 10.1080/09540121.2025.2465733. Epub 2025 Feb 18.

本文引用的文献

1
Dissecting racial bias in an algorithm used to manage the health of populations.剖析用于管理人群健康的算法中的种族偏见。
Science. 2019 Oct 25;366(6464):447-453. doi: 10.1126/science.aax2342.
2
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.具有高阿片类药物过量死亡率和提供阿片类药物使用障碍治疗能力低的美国县的特征。
JAMA Netw Open. 2019 Jun 5;2(6):e196373. doi: 10.1001/jamanetworkopen.2019.6373.
3
Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.安全网中时间压力对阿片类药物管理的来源及影响
J Am Board Fam Med. 2019 May-Jun;32(3):375-382. doi: 10.3122/jabfm.2019.03.180306.
4
Pleasure and PrEP: Pleasure-Seeking Plays a Role in Prevention Choices and Could Lead to PrEP Initiation.性愉悦与 PrEP:性愉悦在预防措施选择中扮演角色,并可能导致 PrEP 的启动。
Am J Mens Health. 2019 Jan-Feb;13(1):1557988319827396. doi: 10.1177/1557988319827396.
5
Does more medicine make us sicker? Ivan Illich revisited.药物越多会让我们病得越重吗?重温伊万·伊里奇的观点。
Gac Sanit. 2019 Nov-Dec;33(6):579-583. doi: 10.1016/j.gaceta.2018.11.006. Epub 2019 Feb 2.
6
PrEP Disparities.暴露前预防差异
JAMA. 2018 Dec 11;320(22):2304. doi: 10.1001/jama.2018.18947.
7
HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.HIV 暴露前预防,按种族和族裔划分-美国,2014-2016 年。
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150. doi: 10.15585/mmwr.mm6741a3.
8
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline.美国疾病预防控制中心 2016 年阿片类药物指南发布前后的阿片类药物处方情况。
Ann Intern Med. 2018 Sep 18;169(6):367-375. doi: 10.7326/M18-1243. Epub 2018 Aug 28.
9
Queer Theory and Biomedical Practice: The Biomedicalization of Sexuality/The Cultural Politics of Biomedicine.酷儿理论与生物医学实践:性取向的生物医学化/生物医学的文化政治
J Med Humanit. 2019 Mar;40(1):7-20. doi: 10.1007/s10912-018-9526-0.
10
'It's just an excuse to slut around': gay and bisexual mens' constructions of HIV pre-exposure prophylaxis (PrEP) as a social problem.“这只是滥交的借口”:男同性恋者和双性恋男性将暴露前预防(PrEP)视为一个社会问题的观念
Sociol Health Illn. 2018 Nov;40(8):1391-1403. doi: 10.1111/1467-9566.12765. Epub 2018 Jul 27.

应对风险,冒险治疗:艾滋病病毒/艾滋病和阿片类药物流行中的医源性经历。

Treating risk, risking treatment: experiences of iatrogenesis in the HIV/AIDS and opioid epidemics.

作者信息

Textor Lauren, Schlesinger William

机构信息

Department of Anthropology and David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

出版信息

Anthropol Med. 2021 Jun;28(2):239-254. doi: 10.1080/13648470.2021.1926916. Epub 2021 Jun 30.

DOI:10.1080/13648470.2021.1926916
PMID:34190020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8639210/
Abstract

This paper explores how poor health outcomes in the HIV/AIDS and opioid epidemics in the United States are undergirded by iatrogenesis. Data are drawn from two projects in Southern California: one among men who have sex with men (MSM) engaging with pre-exposure prophylaxis to HIV (PrEP) and the other in a public hospital system encountering patients with chronic pain and opioid use disorder (OUD). Ethnographic evidence demonstrates how efforts to minimize risk via PrEP and opioid prescription regulation paradoxically generate new forms of risk. Biomedical risk management paradigms engaged across the paper's two ethnographic field sites hinge on the production and governance of deserving patienthood, which is defined by providers and experienced by patients through moral judgments about risk underlying both increased surveillance and abandonment. This paper argues that the logic of deservingness disconnects clinical evaluations of risk from patients' lived, intersectional experiences of race, class, gender, and sexuality. This paper's analysis thus re-locates patients in the context of broader historical and sociopolitical trajectories to highlight how notions of clinical risk designed to protect patients can in fact imperil them. Misalignment between official, clinical constructions of risk and the embodied experience of risk borne by patients produces iatrogenesis.

摘要

本文探讨了医源性因素如何影响美国艾滋病毒/艾滋病和阿片类药物流行中不良健康结果的产生。数据来自南加州的两个项目:一个是针对男男性行为者(MSM)的暴露前预防艾滋病毒(PrEP)项目,另一个是在公立医院系统中针对慢性疼痛和阿片类药物使用障碍(OUD)患者的项目。人种志证据表明,通过PrEP和阿片类药物处方监管来降低风险的努力,反而产生了新的风险形式。本文两个民族志研究地点所涉及的生物医学风险管理范式,取决于应得患者身份的产生和治理,这是由医疗服务提供者定义的,患者通过对增加监测和被抛弃背后风险的道德判断来体验。本文认为,应得性逻辑将对风险的临床评估与患者在种族、阶级、性别和性取向方面的交叉生活经历分离开来。因此,本文的分析将患者置于更广泛的历史和社会政治轨迹背景中,以突出旨在保护患者的临床风险观念实际上如何危及他们。官方临床风险建构与患者所承担的风险具体体验之间的不一致产生了医源性因素。